Adenosine-to-inosine (A-to-I) editing, catalysed by Adenosine DeAminases acting on double-stranded RNA (dsRNA) (ADAR), occurs predominantly in the 3' untranslated regions (3'UTRs). Here we uncover an unanticipated link between ADARs (ADAR1 and ADAR2) and the expression of target genes undergoing extensive 3'UTR editing. Using METTL7A (Methyltransferase Like 7A), a novel tumor suppressor as an exemplary target gene, we demonstrate that its expression could be repressed by ADARs beyond their RNA editing and dsRNA binding functions. ADARs interact with Dicer to augment the processing of pre-miR-27a to mature miR-27a. Consequently, mature miR-27a targets the METTL7A 3'UTR to repress its expression level. In sum, our study unveils that the extensive 3'UTR editing is merely a footprint of ADAR binding, and is dispensable for the regulation of at least a subset of target genes. Instead, ADARs contribute to cancer progression by regulating cancer-related gene expression through their non-canonical functions independent of RNA editing and dsRNA binding.
ADARs have been found to be critical for normal development through and/or beyond A-to-I editing in different genetically modified animal models. Notably, the early post-natal lethality of the Adar2-/-mouse could be rescued by the ectopic expression of edited glutamate receptor subunit B (GluR-B), suggesting the editing activity of ADAR2 is essential for normal mouse development (Higuchi et al. 2000) . However, whether ADAR1 editing activity is similarly responsible for the embryonic lethality of Adar1-/-mouse remains unclear, as the major editing targets of ADAR1 which are of high biological importance remain to be identified Hartner et al. 2004 ).
Furthermore, the primary microRNA (pri-miRNA) cleavage by Drosha/DGCR8 complex was also found to be inhibited by ADARs independent of their editing activities in both cell culture and the Drosophila models (Heale et al. 2009 ). Combining these editing-independent observations with the fact that humans have an editing-incompetent ADAR3 (Chen et al. 2000) , it is most likely that ADARs can exert important functions as RNA binding proteins or through the formation of binding complexes with other proteins, beyond functioning as editing enzymes per se.
Hepatocellular carcinoma (HCC) is the most common type of liver malignancy, and accounts for approximately 700,000 cancer associated deaths per year worldwide (Ferlay et al. 2010) . As reported previously, the deregulated RNA editing enzyme ADARs, as reflected by overexpression of ADAR1 Qi, L., et al., Page 4 and down-regulation of ADAR2, occurs in more than 50% of patients with HCC , rendering a disrupted RNA editing balance in both coding and non-coding regions (Chen et al. 2013; Chan et al. 2014) . Moreover, the recurrent editing of AZIN1 (antizyme inhibitor 1) which converts the codon 367 from serine to glycine has been demonstrated to predispose HCC development (Chen et al. 2013 ). However, most of A-to-I RNA editing occurs in the non-coding regions, and is particularly enriched in 3'UTRs (Peng et al. 2012 ). The contributions of 3'UTR editing by ADARs to cancer development have not yet been illustrated. Moreover, whether major regulatory mechanisms of ADARs on the expression of target genes with promiscuously edited 3' UTRs are independent or dependent of their RNA editing capability, remain to be further explored.
To this end, we carried out the first systematic analysis of A-to-I editing events within 3'UTRs using our previously published RNA-Sequencing (RNA-Seq) datasets of 3 matched pairs of primary hepatocellular carcinoma (HCC) tumors and their adjacent non-tumor (NT) liver specimens (Chen et al. 2013; Chan et al. 2014) , followed by the evaluation of a direct link between RNA editing at 3'UTRs and the expression of target transcripts. Surprisingly, a majority of target pre-mRNA transcripts with extensive editing at their 3'UTRs were found to be regulated by ADARs independent of their deaminase and dsRNA binding functions, providing new insights that the multiple A-to-I editing at 3'UTRs might be merely a footprint of ADAR binding, which is dispensable for the regulation of target gene expression. As an exemplary target gene with multiple editing sites at its 3'UTR, METTL7A could be regulated through a non-canonical regulatory mechanism of ADARs in which ADARs act as a modulator of the RNAi machinery rather than RNA editing. We also found that the downregulation of METTL7A by ADARs has biological implication in cancer development.
Results

Regulation by ADARs on the expression of target genes undergoing extensive A-To-I editing at 3'UTR sequences
Genes with extensive 3'UTR editing were selected based on our previously published RNAsequencing (RNA-Seq) datasets , which have been generated from 3 paired primary HCC tumors and their adjacent NT liver specimens (Supplemental Data, Supplemental Fig. S1 ). To investigate if there exists any functional interaction between ADARs and the edited 3'UTRs, we constructed a 3'UTR-luciferase reporter system (Luc-3'UTRs) containing full-length 3'UTR sequences of 6 selected genes (CCNYL1, TNFAIP8L1, MDM2, METTL7A, MTDH and RBBP9) Supplemental Table S1 ). Genetic structures of these 6 genes are illustrated in Fig. 1A . Co-transfection of Luc-3'UTRs together with the ADAR1-p110 (the isoform responsible for pre-mRNA editing (Farajollahi and Maas 2010) ) or ADAR2 expression Qi, L., et al., Page 5 constructs into HEK293T cells demonstrated that both ADAR1 and ADAR2 had suppressive effects on the luciferase activities linked to 3'UTRs of TNFAIP8L1 and METTL7A gene, and the luciferase activities associated with CCNYL1, MDM2 or RBBP9 3' UTRs were only inhibited upon ADAR2 overexpression; however, neither ADAR1 nor ADAR2 demonstrated any effect on MTDH 3'UTR ( Fig.   1B , Supplemental Fig. S3 ).
Given the significantly reduced luciferase activities by ADAR1 and/or ADAR2, METTL7A and RBBP9 were selected for further investigation whether they are bona fide editing targets and more importantly, the suppressive effects of ADARs on their expression. In the light of the fact that a double stranded RNA (dsRNA) structure is essential for ADARs binding and A-to-I RNA editing (Farajollahi and Maas 2010) , 3'UTR sequences of both METTL7A and RBBP9 are predicted to form long dsRNA secondary structures using CentroidFold (Sato et al. 2009 ) (Supplemental Fig. S4 ). As expected, in HEK293T cells transfected with increasing amounts of either ADAR1 or ADAR2 expression construct, a dose-dependent reduction in luciferase activity of pmirGLO-METTL7A-3'UTR correlated negatively with the increase in the average editing frequency of 10 editing sites in the METTL7A 3'UTR ( Fig. 1C -E; Supplemental Fig. S5A ). As for RBBP9, we did observe a negative correlation between the luciferase activity of pmirGLO-RBBP9-3'UTR and the expression level of ADAR2 but not with ADAR1, in a dose-dependent manner ( Fig. 1F ). Unexpectedly, none of 6 edited sites within the RBBP9 3'UTR demonstrated any increase in editing levels (Supplemental Fig. S5A, B ). Altogether, we have shown that the expression of METTL7A and RBBP9 could be regulated by ADAR1 and/or ADAR2; however whether this regulation is through an RNA editing-dependent or independent mechanism requires further investigation. Although we observed the significantly reduced 3'UTR-associated luciferase expression of CCNYL1 and TNFAIP8L1 upon ADAR1 or/and ADAR2 overexpression ( Fig.   1B ), there was no obvious change in the editing frequencies of their 3'UTR editing sites (Supplemental Fig. S5C ). All these data suggests ADARs are most likely to regulate the expression of target genes undergoing extensive 3'UTR editing beyond their catalytic functions.
RNA editing/dsRNA binding-independent suppression of ADARs on target genes
To this end, we generated different ADARs mutants devoid of either the enzymatic activity (DeAD mutants) (Lai et al. 1995) or the dsRNA binding capability (EAA mutants) (Valente and Nishikura 2007) , which are both required for A-to-I RNA editing (Supplemental Methods, Supplemental Fig. S6 ). Editing frequencies of 10 editing sites within the METTL7A 3'UTR were examined in cells transfected with either wild-type or mutant form of ADARs ( Fig. 2A, B ). Consistent with a previous report (Valente and Nishikura 2007) , ADARs DeAD mutants functioned as dominant Qi, L., et al., Page 6 negative forms, as they could compete for homodimerization with endogenous wild-type ADARs, rendering the wild-type partners inactive. As for ADARs EAA mutants, there was no significant difference in the basal editing level of METTL7A 3'UTR when compared to the control (ADAR1 EAA: P = 0.14; ADAR2 EAA: P = 0.47) ( Fig. 2A, B ), which might be attributed to the loss of dimerization ability of EAA mutants (Poulsen et al. 2006) . Consistent with the data described above (Fig. 1B) , luciferase activities of pmirGLO-METTL7A-3'UTR and pmirGLO-TNFAIP8L1-3'UTR could be suppressed by both wild-type and mutant forms of ADARs (Fig. 2C, E ). Luciferase activities linked to 3'UTRs of CCNYL1 and RBBP9 were only suppressed by different forms of ADAR2 in HEK293T cells ( Fig. 2D, F) . Similar effects of different ADAR forms on luciferase activities of pmirGLO-METTL7A-3'UTR and pmirGLO-RBBP9-3'UTR were also observed in the HCC cell line SNU-398 (Supplemental Fig. S7 ). All these data strongly suggests a non-canonical regulatory function of ADARs on gene expression through 3'UTRs independent of RNA editing and dsRNA binding.
Suppression by ADARs on METTL7A expression in HCC cells and primary tumors
To demonstrate that our observations have biological implications in cancer development, beyond exogenous luciferase reporter assays, the METTL7A gene was selected for further investigation of ADARs-mediated effects on endogenous gene expression. Due to the neutral effects of EAA mutants on A-to-I editing and its loss of dsRNA binding capability, EAA mutants of ADARs were included in the remainder of this study. Both wild-type and EAA mutants inhibited endogenous METTL7A expression at both mRNA and protein levels in the HCC cell line Huh-7, which has the highest endogenous METTL7A expression among 9 HCC cell lines ( Fig. 3A To study if this non-canonical regulatory mechanism is of high biological importance during cancer development, we went on to examine ADARs-mediated suppression on METTL7A expression in 15 paired primary HCC tumor and their matched NT liver specimens. Patients with HCC were divided into 2 groups: ADAR1 high /ADAR2 high or normal (n=11) and ADAR1 low /ADAR2 low (n=4) (Supplemental Methods, Supplemental Fig. S9 ). When compared to their matched NT specimens, all of ADAR1 high /ADAR2 high or normal HCCs demonstrated either lower or absent expression of METTL7A ( Fig. 3D) ; while 3 out of 4 (75%) ADAR1 low /ADAR2 low HCCs demonstrated an increase or no change in METTL7A expression ( Fig. 3E ). This suggests the ADARs-mediated suppression may be a major mechanism of METTL7A downregulation in HCCs. Qi, L., et al., Page 7 
MiR-27a as a mediator between ADARs and METTL7A
In light of the fact that 3'UTR is the major miRNA targeting region, miRNAs are most likely to mediate this non-canonical regulation of ADARs on METTL7A expression. Editing-independent effects of ADARs on RNA interference (RNAi) and miRNA processing, which were first delineated in Drosophila (Heale et al. 2009) , have been recently observed in mammalian systems (Ota et al. 2013) .
In order to identify miRNAs targeting METTL7A, the METTL7A 3'UTR sequence was subjected to miRNA prediction using miRWalk across multiple algorithms (miRanda, miRDB, miRWalk, RNA22 and Targetscan) (Dweep et al. 2011) . Only miRNAs that can be predicted by at least 2 algorithms were selected for further investigation. As seen in Fig. 4A , the introduction of miR-27a into HEK293T cells significantly repressed the luciferase activity of pmirGLO-METTL7A-3'UTR, indicating that miR-27a might truly target the METTL7A 3'UTR. Further, the luciferase activity of pmirGLO-METTL7A-3'UTR was found to be repressed by miR-27a, in a dose-dependent manner (Fig.   4B ). Subsequently, the pmirGLO-METTL7A-3'UTR mutant was constructed by mutating the seed region (indicated by box; Fig. 4C ) in the pmirGLO-METTL7A-3'UTR construct. Transfection of the pmirGLO-METTL7A-3'UTR mutant into HEK293T cells completely abolished the inhibition by miR-27a of the luciferase activity ( Fig. 4C) , indicating a direct interaction between miR-27a and the METTL7A 3'UTR. Moreover, the expression of endogenous METTL7A protein was also found to be inhibited by miR-27a in Huh-7 cells (Fig. 4D) .
Importantly, we further confirmed that there was no A-to-I editing occurring in miR-27a and its targeted METTL7A 3'UTR sequences, ruling out the possibility that the impact of ADARs on METTL7A expression is via the enhancement of miR-27a:METTL7A mRNA interaction arising from the A-to-I editing of miR-27a and/or its target METTL7A 3'UTR sequence (Fig. 4E ).
ADARs interact with dicer to promote miR-27a expression independent of RNA editing/dsRNA binding activities
If miR-27a is a key mediator for ADARs-mediated suppression of METTL7A, both the wild-type and EAA mutants of ADARs are predicted to upregulate miR-27a. Indeed, mature miR-27a was found to be upregulated upon overexpression of either wild-type or EAA mutants of ADARs in Huh-7 cells ( Fig. 5A) . We went on to study which stage of miR-27a biosynthesis could be targeted by ADARs.
There was no obvious increase in the expression of miR-27a precursors, pri-miR-27a, and pre-miR-27a, upon the overexpression of either wild-type or EAA mutant (Fig. 5B, C) . Further, Northern blot analysis for miR-27a confirmed that the introduction of both wild-type and EAA forms of ADARs could process pre-miR-27a to mature miR-27a more efficiently than the control (Fig. 5D ). All these Qi, L., et al., Page 8 observations indicated that processing of pre-miR-27a to mature miR-27a is likely to be regulated by ADARs independent of RNA editing and dsRNA binding.
Processing of pre-miRNAs to miRNAs is catalysed by Dicer in complex with TRBP (Tar RNA binding protein) (Winter et al. 2009 ). Also, it has been recently reported that ADAR1 promote pre-miRNA processing via binding to Dicer (Ota et al. 2013) . Therefore, we hypothesized that both ADARs promote miR-27a processing and expression through interacting with Dicer. As expected, endogenous Dicer was detected in both FLAG-tagged wild-type and EAA mutant pull-down products (Fig. 5E ). Reciprocally, FLAG-tagged wild-type ADARs and EAA mutants could also be detected in anti-Dicer immunoprecipitates (Fig. 5E ). More importantly, the reciprocal pull-down assays indicated endogenous Dicer could interact with both ADAR1 and ADAR2 in Huh-7 cells (Fig. 5F ). The observed interaction between ADAR1 and ADAR2, known to form heterodimer in human cells (Chilibeck et al. 2006; Cenci et al. 2008) , serves as positive controls. Taken together, ADARs are found to augment the processing of pre-miR-27a to mature miR-27a via binding to Dicer, in turn targeting the METTL7A 3'UTR and decreasing METTL7A expression.
METTL7A as a novel tumor suppressor in HCC
Having identified a non-canonical function of ADARs beyond their catalytic and dsRNA-binding capabilities, we sought to demonstrate that the altered expressions of target genes has a biological impact on cancer development. METTL7A expression was analysed using RNA-Seq datasets from the Cancer Genome Atlas (TCGA) project (Weinstein et al. 2013 ) and a microarray gene expression dataset from the NCBI Gene Expression Omnibus (GEO) database (GEO542361) (Villa et al. 2015) .
Both datasets confirmed significantly decreased expression of METTL7A in HCC tumors compared to adjacent NT tissues, and also predicted shorter overall survival for patients with HCC ( Fig. 6A, B) .
To further investigate the role of METLL7A in HCC development, 3 HCC cell lines (SNU-398, SNU-449, and Huh-7) were selected for establishing overexpression and knockdown cell models and the subsequent functional studies (Fig. S10A, B) . As detected by cell culture assays predictive of tumorigenicity, overexpression of METTL7A in both SNU-449 and SNU-398 cells (398-M7A and 449-M7A) significantly reduced the cell viability, frequency of focus formation, and the number of colonies formed in soft agar when compared to cells transduced with empty vector lentiviruses (398-EV & 449-EV) ( Fig. 6C-E) . Moreover, xenograft tumors derived from 398-M7A cells, with overexpression of METTL7A, grew much slower than tumors derived from 398-EV cells during a 3week observation period (Fig. 6F) . Conversely, specific shRNAs-mediated silencing of METTL7A augmented the tumorigenicity of Huh-7 cells, as indicated by the increased cell viability and higher frequency of colony formation in soft agar (Fig. 6G, H; Fig. S10C ). As seen in Fig. 6I, xenograft tumors derived from stably knockdown cells (Huh7-shM7A_b) grew much more aggressively than Qi, L., et al., Page 9 tumors derived from control cells (Huh7-shCTL), as a consequence of the persistent silencing of METTL7A during a 4-week observation period (Fig. 6I ). All these data suggests that METTL7A downregulation, possibly mainly due to the RNA editing/binding-independent suppression by ADARs, is closely linked to HCC development.
Discussion
Extensive A-to-I editing at 3'UTR sequences has been associated with different fates of the edited pre-mRNA transcripts. Due to the distinct base pairing preference between adenosine and inosine, RNA editing at 3'UTRs can regulate the stability of target transcripts by creating or eliminating miRNA targeting sites (Borchert et al. 2009; Wang et al. 2013) . Alternatively, the promiscuously edited 3'UTRs can recruit inosine-specific nucleases, e.g. the RNA-induced silencing complex (RISC) subunit Tudor-SN and human endonuclease V, leading to mRNA degradation (Scadden 2005; Morita et al. 2013) . Certain transcripts with edited 3'UTRs were shown to be retained in the nucleus by an inosine-specific nuclear protein complex composed of P54 nrb , splicing factor PSF, and matrin-3 (refs (Prasanth et al. 2005; Nishikura 2010) ). All of the above reported fates of inosine-containing RNAs highlighted the importance of inosine in either changing the base-pairing properties or recruiting inosine-specific protein complexes, thereby affecting the translational efficiency of the edited mRNAs.
In contrast, a previous study in C. elegans reported no significant difference in expression of mRNAs with structured and edited 3'UTRs across different adr strains (Hundley et al. 2008 ). Furthermore, mRNAs with edited 3'UTRs have been demonstrated to associate with translating polyribosomes in both C. elegans and human HeLa cells, indicating that not all the edited mRNAs are retained in the nucleus (Hundley et al. 2008 ). Thus, a relevant question is whether RNA editing is necessary to induce the observed effect of ADARs on 3'UTRs? Surprisingly, using different ADAR mutants which are devoid of either RNA editing or dsRNA binding capability, we found the promiscuous A-to-I editing within 3'UTRs of transcripts is most likely to be a footprint of ADARs binding, which is not required for the manipulation of target gene expression, at least for a subset of targets. Relatively few protein variants produced by RNA editing have been demonstrated to be causative of biological phenotypes observed in animal models with genetically modified ADARs suggesting that editing-independent functions of ADARs might also be of importance in the observed phenotypes (Nie et al. 2005) . Furthermore, a recent study suggested that the ADAR1 binding to non-Alu regions could affect 3'UTR usage through competing with 3'UTRbinding factors, such as cleavage and polyadenylation-relevant proteins (Bahn et al. 2015) , thereby influencing the expression of target genes. More importantly, the impact of ADAR1 on 3'UTR usage is only dependent on RNA editing for certain 3'UTRs, but others could be affected by ADAR1 in an Qi, L., et al., Page 10 editing-independent manner. In this study, 5 out of the 6 selected genes carrying multiple editing sites at 3'UTRs were found to be regulated by ADAR1 and/or ADAR2 beyond their deaminase and dsRNA binding functions. Therefore, the functional significance of ADARs is much more diverse than previously appreciated and this gene regulatory function of ADARs may be of higher importance than the better-studied editing function.
Until now, gene regulatory mechanisms of ADARs have not been clearly understood. Given the fact that ADAR-mediated A-to-I RNA editing competes for shared dsRNA substrates with RNAi machinery, interactions between ADARs and RNAi pathway have gained intensive attention during the past decade (Nishikura 2006) . Effects of hyper-editing in protecting dsRNA from entering RNAi were first confirmed by biochemical assays, and further observed in C. elegans with adr-1/adr-2 double mutant models (Scadden and Smith 2001; Tonkin and Bass 2003) . Editing of primary miRNAs has been reported to inhibit miRNA biosynthesis at multiple stages, e.g. Drosha and Dicer cleavage, the loading to RISC, or redirecting silencing targets Kawahara et al. 2007a; Kawahara et al. 2007b; Kawahara et al. 2008; Iizasa et al. 2010) . In contrast to antagonistic effects of ADARs on the RNAi pathway, a recent study on the impact of ADAR1 on pri-miRNA processing in the nucleus suggested that ADAR1 might enhance pri-mRNA processing via its interaction with the pri-mRNAs prior to Drosha/DGCR8 binding, which may not rely on RNA editing (Bahn et al. 2015) .
This finding complements the previous report that the interaction between ADAR1 and RISC component proteins revealed an editing-independent agonistic effect of ADAR1 on miRNA processing, by forming a complex with Dicer in the cytoplasm (Ota et al. 2013 ). Here, our mechanistic studies focused on METTL7A, an exemplary target gene with multiple editing sites in its 3'UTR, indicated that the interaction of ADARs with Dicer augments the processing from pre-miR-27a to mature miR-27a and subsequent miR-27a targeting of the METTL7A 3'UTR, leading to reduced expression of METTL7A. Thus, our study represents the first report that both ADAR1 and ADAR2 can augment miRNA processing from pre-miRNAs to mature miRNAs through interacting with Dicer, independent of RNA editing and dsRNA binding. It is likely that a large amount of genes are regulated by ADARs via non-canonical editing/dsRNA binding-independent mechanism(s), such as CCNYL1, MDM2, TNFAIP8L1, and RBBP9, which have been identified in this study. However, for other target genes, the precise regulatory mechanism(s) of ADARs will need to be examined on a case-by-case basis.
The next question is whether this mechanism may have important functional relevance in cancer development. As an exemplary target gene undergoing 3'UTR editing, METTL7A was identified to be a tumor suppressor in HCC. Moreover, the survival analysis of 2 individual HCC cohorts indicated the tumoral downregulation of METTL7A predicted poor prognosis of patients with HCC. Unexpectedly, even with multiple editing sites in the 3'UTR, the expression of METTL7A was found to be regulated by ADARs through miRNA expression modulation in an RNA editing and RNA binding-independent Qi, L., et al., Page 11 manner. Given the widespread effects of miRNA targeting, METTL7A will likely not be the only target influenced by ADARs under this mechanism. Recent studies reported the expression of miRNAs is globally inhibited in adar1 -/mouse embryos, in turn altering the expression of miRNA target genes (Ota et al. 2013) . Also, in human U87MG cells, a gene otology (GO) analysis of target genes of ADAR1-affected miRNA yields a number of genes functionally enriched in pathways related to cell proliferation, growth, apoptosis and cellular response to stimuli or DNA damage (Bahn et al. 2015) .
Our study revealed that the functional essentiality/importance of ADARs is likely to stem from its involvement in processes other than RNA editing and dsRNA binding alone, at least for a subset of target genes relevant to cancer development. As we and other have demonstrated, the enhancement of miRNA processing via the interaction between ADARs and Dicer (Ota et al. 2013) or Drosha (Bahn et al. 2015 ) may function as a major mechanism responsible for gene regulatory function of ADARs beyond their deaminase and RNA binding activities. Disruption of the interaction between ADARs and Dicer or Drosha might represent a targetable approach for rescuing expression of tumor suppressors such as METTL7A as a novel therapeutic modality in HCC and other cancers. Qi, L., et al., Page 12 
Methods
Cell lines
SNU-398, SNU-449, and HEK293T cell lines were purchased from the American Type Culture Collection (ATCC). Huh-7 was purchased from Japanese Collection of Research Bioresources Cell Bank (JCRB). SMMC-7721 was purchased from Thermo Fisher Scientific, MA, USA. SNU-398 and SNU-449 cells were cultured in Roswell Park Memorial Institute (RPMI) medium (Gibco BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS) (Gibco BRL). Huh-7, SMMC-7721, and HEK293T cells were maintained in Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% FBS. All cell lines used in this study were regularly authenticated by morphological observation and tested for mycoplasma contamination (MycoAlert, Lonza Rockland, Rockland, ME). The cells were incubated at 37 °C in a humidified incubator containing 5% CO 2 .
Clinical samples
Total of 15 paired human primary HCC and adjacent NT liver tissues that were surgical removed and snap frozen in liquid nitrogen were obtained from the tissue repository of National University Hospital (NUH), Singapore. All patients gave written informed consent for the use of their clinical specimens for medical research. All samples used in this study were approved by the Institutional Review Board of National University of Singapore (NUS-IRB) (Reference Code: B-14-239E).
Publically available databases
Two publically available datasets for survival data analysis of patients with HCC with respect to METTL7A expression: RNA-Seq datasets (including 370 HCC tumors and 50 adjacent NT liver samples) from TCGA (LIHC) (Weinstein et al. 2013 ) (https://tcga-data.nci.nih.gov/tcga/) and microarray gene expression datasets (including 81 HCC tumors and 80 adjacent NT liver samples) from GEO54236 (Villa et al. 2015) (http://www.ncbi.nlm.nih.gov/gds). Prior to the survival analysis, raw RNA-Seq counts were normalized using the total numbers of mappable reads across all samples, while the microarray data normalization was performed using the Cross-Correlation method (Chua et al. 2006 ). Normalized and log2 transformed METTL7A expression data were subjected to the survival analysis using Kaplan-Meier plots and log-rank tests. The median tumoral METTL7A expression was used to define METTL7A-high and METTL7A-low groups of patients with HCC for both datasets.
The METTL7A expression in tumors and matched NT tissues were compared using the Mann-Whitney U test. Qi, L., et al., Page 13 The SPSS statistical package for Windows, version 16 (SPSS), and Microsoft Excel (Excel in Microsoft Office 2013 for Windows) were used for data analysis. The expression of METTL7A in tumors and matched NT tissues were compared using the Mann-Whitney U test. The relative editing frequencies of 10 representative editing sites at METTL7A 3'UTR in response to overexpression of the control or different ADARs in HEK293cells were compared using the Mann-Whitney U test. Kaplan-Meier plots and log-rank tests were used for overall survival analysis. The unpaired, two-tailed Student's t test was used to compare the number of foci, colony formation, tumor volume and relative expressions of target genes, the luciferase activities between any two preselected groups. P < 0.05 was considered statistically significant. low: n=40 for GEO54236; n=185 for LIHC) which was categorized based on the median expression of 
Statistical analysis
